Selena Gomez has been in the spotlight thanks to her Golden Globe nomination for Emilia Pérez and her engagement to musician ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
22h
GlobalData on MSNRoyalty Pharma pays $250m for rights to Biogen’s lupus drugRoyalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus medication litifilimab. In return, Royalty Pharma will receive undisclosed ...
People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...
The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...
The Lupus Foundation of America is a nonprofit whose mission is to "improve the quality of life for all people affected by ...
The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...
Topical mupirocin helps reduce inflammation in lupus, offering a potential new approach for managing symptoms and improving ...
While Roche’s Gazyva has been on the market for a dozen years and has won four approvals from the FDA, it is making a late ...
The event raised awareness for those with lupus, a chronic autoimmune disease that leads the body’s immune system to attack ...
Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles River Laboratories to help test the asset in a preclinical model of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results